未登录 UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA 更新后的III期STELLAR试验结果：依氟鸟氨酸改善2021年WHO分级3级IDH突变型星形细胞瘤患者的总生存期和盲态独立中央审查确定的无进展生存期 Colman, Howard; Lombardi, Giuseppe; Wong, Eric; Walbert, Tobias; Eoli, Marica; Lassman, Andrew; Peereboom, David; Kizilbash, Sani; Kamiya-Matsuoka, Carlos; Pitz, Marshall; Strowd, Roy; Desjardins, Annick; Kumthekar, Priya; Mason, Warren; Pellerino, Alessia; Soffietti, Riccardo; Butowski, Nicholas; Forsyth, Peter; Hamza, Mohamed; Hau, Peter; Lallana, Enrico; Nabors, Burt; Piccioni, David; Uhlmann, Erik; Welsh, Liam; Wen, Patrick; Dietrich, Jorg; Levin, Victor 分享 收藏
Volumetric (3D) compared with traditional bidirectional (2D) assessment in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial 与接受vorasidenib或安慰剂治疗的Grade 2，异柠檬酸脱氢酶1/2突变（mIDH1/2）胶质瘤患者中，体素（3D）评估相较于传统双向（2D）评估在INDIGO III期试验中的比较 Ellingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F. 分享 收藏
PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) IN PATIENTS WITH CNS LYMPHOMA 计划用于门诊高剂量甲氨蝶呤（HD-MTX）治疗中枢神经系统淋巴瘤患者的葡糖醛酸酶。 Schaff, Lauren; Lobbous, Mina; Schofield, Ryan; Carlow, Dean; Gonzalez, Ashley; Emadi-Paramkouhi, Laleh; Kahleifeh, Adam; Reiner, Anne; Panageas, Katherine; Nabors, Louis B.; Deangelis, Lisa; Mellinghoff, Ingo; Grommes, Christian 分享 收藏
PLANNED GLUCARPIDASE FOR CNS LYMPHOMA PATIENTS AT HIGH RISK OF METHOTREXATE (MTX) TOXICITY 计划为高风险甲氨蝶呤（MTX）毒性中枢神经系统淋巴瘤患者使用葡萄糖醛酸酶。 Schaff, Lauren; Lobbous, Mina; Kahleifeh, Adam; Schofield, Ryan; Carlow, Dean; Reiner, Anne; Panageas, Katherine; Nabors, Louis B.; Deangelis, Lisa; Mellinghoff, Ingo; Grommes, Christian 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Association of proton pump inhibitor use with outcome of patients with newly diagnosed glioblastoma 质子泵抑制剂使用与新诊断胶质母细胞瘤患者预后的关联 Le Rhun, Emilie; Sain, Debaleena; Erridge, Sara C.; Reardon, David; Minniti, Giuseppe; Roth, Patrick; Wick, Wolfgang; Nabors, Burt; Sampson, John; Mason, Warren; Cloughesy, Tim; Reijneveld, Jacob C.; Stupp, Roger; Preusser, Matthias; Gorlia, Thierry; Weller, Michael 分享 收藏
分享 收藏
Volumetric tumor growth rate (TGR) modeling predicts clinical outcomes in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial 体积肿瘤生长率（TGR）建模预测了在INDIGO三期试验中，接受vorasidenib或安慰剂治疗的Grade 2、异柠檬酸脱氢酶1/2突变（mIDH1/2）胶质瘤患者的临床结局。 Ellingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
EARLY TUMOR VOLUME CHANGES PREDICT CLINICAL OUTCOMES IN MIDH1/2 GLIOMA: POST-HOC RESULTS FROM THE PHASE 3 INDIGO TRIAL 早期肿瘤体积变化预测Midh1/2胶质瘤的临床结局：INDIGO III期试验的事后分析结果 Ellingson, B. M.; Mellinghoff, I. K.; van den Bent, M. J.; Blumenthal, D. T.; Touat, M.; Peters, K. B.; Clarke, J. L.; Mendez, J.; Yust-Katz, S.; Welsh, L.; Mason, W. P.; Ducray, F.; Umemura, Y.; Nabors, B.; Holdhoff, M.; Hottinger, A. F.; Arakawa, Y.; Sepulveda, J. M.; Wick, W.; Soffietti, R.; Perry, J.; Giglio, P.; de la Fuente, M.; Maher, E.; Zhao, D.; Pandya, S. S.; Steelman, L.; Hassan, I; Wen, P. Y.; Cloughesy, T. F. 分享 收藏
ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA 质子泵抑制剂使用与 Newly Diagnosed Glioblastoma 患者预后的关联 Le Rhun, E.; Sain, D.; Sara, E. C.; Reardon, D. A.; Minniti, G.; Roth, P.; Wick, W.; Nabors, B.; Sampson, J.; Mason, W.; Cloughesy, T.; Reijneveld, J. C.; Stupp, R.; Preusser, M.; Gorlia, T.; Weller, M. 分享 收藏
分享 收藏
分享 收藏
Phase I Clinical Trial of M032, an IL-12 Expressing Oncolytic HSV-1, for Adult Patients With Recurrent Malignant Glioma Estevez-Ordonez, Dagoberto; Stein, John; Malekenia, Pedram; Gallegos, Carlos; Atchley, Travis; Laskay, Nicholas M.; Clements, Jennifer; Leavenworth, Jianmei; Riley, Kristen O.; Lobbous, Mina; Aban, Inmaculada; Sorace, Ana; Nabors, Burt; Markert, James M. 分享 收藏
The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysis Sun, Y.; Hamo, M.; Atchley, T.; Nabors, B.; Markert, J.; Estevez-Ordonez, D. 抗抑郁药对胶质母细胞瘤生存的影响：一项系统评价和荟萃分析。Neurooncol. Adv. 2025, 7, vdaf75. [Google Scholar] [CrossRef] [PubMed] Sun, Yifei; Hamo, Mohammad; Atchley, Travis; Nabors, Burt; Markert, James; Estevez-Ordonez, Dagoberto 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
NEURO-ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏